Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation...

Area of Science:

• Biomedical research
• Stem cell biology
• Molecular mechanisms of bone disease

Background:

• Ethanol-induced osteonecrosis is linked to suppressed osteogenic differentiation of bone marrow stromal stem cells (BMSCs).
• Tumor necrosis factor alpha (TNF-α) and miR-31 are implicated in osteogenic induction.
• Understanding the molecular regulation of osteogenesis in this context is crucial.

Purpose of the Study:

• To investigate the molecular mechanism regulating osteogenic differentiation in BMSCs affected by ethanol-induced osteonecrosis.
• To elucidate the role of TNF-α and miR-31 in this process.

Main Methods:

• Assessed BMSC osteogenic differentiation and proliferation using Alizarin red staining and fibroblast colony-forming assays.
• Quantified gene and protein expression of osteogenesis markers via quantitative real-time PCR and western blot.
• Identified differentially expressed genes using microarray analysis and validated miR-31 targets with luciferase reporter assays.

Main Results:

• BMSCs from patients with ethanol-induced osteonecrosis showed reduced osteogenic differentiation and proliferation.
• TNF-α inhibition significantly improved BMSC osteogenic differentiation and proliferation.
• TNF-α, via miR-31 regulation, suppressed RUNX2 and SATB2 expression, hindering osteoblast differentiation.

Conclusions:

• TNF-α inhibition promotes osteogenic differentiation in BMSCs from ethanol-induced osteonecrosis patients.
• Downregulation of miR-31 by TNF-α inhibitor directly enhances SATB2 and RUNX2 expression.
• This pathway highlights a therapeutic target for ethanol-induced osteonecrosis.